Back
HFA Premium Access

Surgical ablation of the right greater splanchnic nerve (GSN) for the treatment of HFpEF: a prospective, first-in-human clinical trial

Session: Late breaking trial III - Innovative and device therapy
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Speaker: Professor P. Ponikowski (Wroclaw, PL)
Event: Heart Failure 2018

Congress Presentation

About the speaker

Professor Piotr Ponikowski

Wroclaw Medical University, Wroclaw (Poland)
109 presentations
13 followers

11 more presentations in this session

Upgrades from a previous device compared to de novo CRT implantation in the CRT Survey II: a European Society of Cardiology survey of cardiac resynchronization therapy in 11.088 patients

Speaker: Professor C. Linde (Stockholm, SE)

Access
Slides
Video
Thumbnail

Discussion - CRT Survey II

Access
Video
Thumbnail

Long-term outcome in the pivotal MOMENTUM 3 trial: medical resource use and cost implications

Speaker: Professor M. Mehra (Boston, US)

Access
Slides
Video
Thumbnail

Discussion - MOMENTUM 3

Access
Video
Thumbnail

Cardiac contractility modulation improves peak VO2, long-term survival and hospitalisations in heart failure with reduced ejection fraction; evidence from FIX-5C and the EU registry

Speaker: Professor G. Hasenfuss (Goettingen, DE)

Access
Slides
Video
Thumbnail

Access the full session

Late breaking trial III - Innovative and device therapy

Speakers: Professor P. Ponikowski, Professor C. Linde, Professor M. Mehra, Professor G. Hasenfuss
Access
Thumbnail

About the event

Image

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb